Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0S8WA
|
||||
| Former ID |
DNCL002768
|
||||
| Drug Name |
Obinutuzumab
|
||||
| Synonyms |
GA101/RG7159
|
||||
| Drug Type |
Antibody
|
||||
| Company |
Biogen Idec; Genentech
|
||||
| SuperDrug ATC ID |
L01XC15
|
||||
| Target and Pathway | |||||
| Target(s) | B-lymphocyte antigen CD20 | Target Info | [543668] | ||
| KEGG Pathway | Hematopoietic cell lineage | ||||
| References | |||||
| Ref 532651 | 2013 FDA drug approvals. Nat Rev Drug Discov. 2014 Feb;13(2):85-9. | ||||
| Ref 541982 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6941). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.